The aim of this study is to assess the beneficial effects of Bifidobacterium Hydrochloride and Berberine on lowering glucose in patients with type 2 diabetes mellitus and to detect the potential mechanism.
Gut microbiota maybe play an important role in patients with type 2 diabetes mellitus (T2DM). Berberine, which is usually used as an antibiotic drug, has been reported a potential glucose-lowering effect in vitro and in vivo studies. Bifidobacterium, as a familiar probiotics, can modulate gut microbiota and improve glucose and lipid metabolism in animal experiments. Therefore, the aim of this study is to assess the beneficial effects of Bifidobacterium Hydrochloride and Berberine on lowering glucose in patients with T2DM and to detect the potential mechanism.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China
The 323rd Hospital of People's Liberation Army
Xi'an, Shaanxi, China
First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China
Shaanxi Provincial People's Hospital
Xi'an, Shaanxi, China
Change in HbA1c from baseline to week 12
Change was measured at baseline and week 12 after randomization. Change was reported as the absolute difference in % HbA1c.
Time frame: Baseline and week 12
Percentage of subjects achieving HbA1c < 7% at week 12
Time frame: Week 12
Gut microbiome composition
Faecal bacterial composition determined from microbiological cultures and deep metagenomic next-generation sequencing of bacterial DNA in feces.
Time frame: Baseline and week 12
Changes in postprandial glucagon-like peptide-1 (GLP-1) secretion between baseline and week 12
Plasma level of GLP-1 at baseline and week 12 during a 2 hour-meal test.
Time frame: Baseline and week 12
Adverse effects
Standardized questionaries regarding gastrointestinal function are filled out at each study visit (0, 4, 8 and 12 weeks after randomization) to detect possible adverse effects of antibiotics. In addition, subjects are given a calendar and informed to write down any symptom or illness during the study period.
Time frame: From baseline to week 12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.